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WE investigated whether TNB alters colonic tissue levels
of PAF at the expense of changes in colonic motility in
the isolated perfused rabbit left colon. Colonic inflamma-
tion was induced by the intracolonic administration of
0.25 ml of 50% ethanol containing 30 mg of
trinitrobenzene. Strain gauge transducers were sewn
onto the serosal surface of the colon to evaluate colonic
motility. TNB administration increased tissue levels of
PAF and increased the average force of each colonic
contraction. Pretreatment with the PAF receptor antago-
nist WEB-2170 prior to TNB infusion decreased tissue
concentrations ofPAF and ameliorated the altered motil-
ity parameters seen withTNB alone. These results suggest
that PAF is stimulated by TNB and may participate in
colonic dysmotility during inflammatory states.
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Several mediators are involved in the wide spec-
trum of disease states that affect the large bowel both
in models of experimental colitis and in in vivo
profiles of tissue obtained from patients with inflam-
matory bowel disease and other forms of colitis. The
colonic generation of eicosanoids, autacoids such as
platelet-activating factor as well as cytokines have
been implicated in the inflammatory response. Mod-
els of experimental colitis have not only produced
acute inflammation, but also demonstrated distur-
bances in colonic motility. 2,3 Results from this labora-
tory have demonstrated that exogenous PAF pro-
duces not only colonic inflammation similar to that
seen in inflammatory bowel disease, but induces
dysmotility in the colon mediated by neuropeptides.
The aim of the present study was to evaluate the
possible role of endogenous PAF in the dysmotility
changes of the left colon of the rabbit to
trinitrobenzene sulphonic acid (TNB), a hapten
which produces acute mucosal inflammation and
chronic transmural inflammation in experimental
colitis.
The experimental procedure for producing colonic
inflammation by PAF on the isolated rabbit colon has
been reported previously. After isolating the colon,
it was placed on a temperature controlled base,
humidified whole organ perfusion apparatus (Mx
International, Aurora, CO) and allowed to equilibrate
with an intra-arterial Krebs-Ringer’s bicarbonate
(KRB) infusion for the first 30 min period. This was
followed by the intraluminal infusion of 0.25 ml of
50% ethanol containing 30 mg of TNB, while con-
tinuing infra-arterial infusion of KRB for 30 min. At
the end of this period, TNB was discontinued and the
colon was allowed to recover for 30 min, infusing
only KRB intra-arterially. Separate studies were per-
formed in which the colons were pretreated intra-
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arterially with 10-9M of the PAF antagonist WEB-2170
30 min prior to administration of TNB. Strain gauge
transducers were sewn onto the serosal surface of
the colon to measure colonic motility. Motility was
calculated as four indices: (1) contractions/min; (2)
peak force per contraction measured in grams; (3)
average force per contraction; and (4) the minute
motility index (MMI) calculated as the sum of the
contractions, weighed by the peak force, expressed
as a per minute average. At the end of the experi-
ment, tissue samples of colon were taken and im-
mersed in liquid nitrogen and then stored at-70C.
Tissue levels of PAF were determined by a well-
described radioimmunoassay.
Tissue concentrations of PAF in TNB treated
colons were significantly increased compared with
control values. When administered prior to TNB,
WEB-2170 significantly decreased the tissue con-
centrations of PAF. Motility results demonstrated that
TNB did not affect contractility, decreased the peak
force and increased the average force per contrac-
tion. Similarly there was a trend toward decreasing
the MMI. Pretreatment of colons with WEB-2170
prior to TNB administration resulted in peak force,
average force and MMI values to return to that seen
with KRB infusion alone (Table 1).
Colonic inflammation has a complex aetiology
inter-related with the immune system, the
neuroendocrine system and aracidonic acid metabo-
lism. The interaction of these phenomena with
changes in colonic motility has attracted our atten-
tion recently. Endogenous release of PAF is felt to be
partly responsible for the intestinal motor alterations
induced by endotoxin which are strongly reduced
after treatment with a PAF antagonist, and suggested
to be mediated through the release of
prostaglandins. Two recent study of colitis induced
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Table 1. The effect of TNB on tissue PAF and colonic motility
KRB NB WEB-2170 + TNB
(n=5) (n=5) (n=5)
Tissue PAF levels 95.5 + 12.7 294.8 +/- 19.6" 124.8 +/- 31.3"*
Contractions/min 23.5 +/- 1.9 25.3 +/- 3.7 22.1 +/- 4.1
Peak force 0.77 +/- 0.07 0.45 +/- 0.06* 0.83 +/- 0.06**
Average force 0.44 +/- 0.3 0.62 +/- 0.08* 0.36 +/- 0.05**
MMI 37.4 +/- 5.5 29.3 +/- 6.3 35.7 +/- 4.6
p < 0.05, TNB and KRB; **p < 0.05, WEB-2170 + TNB and TNB.
pg/mg wet tissue, peak force per contraction, Average force per
contraction, Minute Motility Index.
by TNB have been described in in vivo rat models of
colitis and motility alterations. TNB instilled in the
proximal colon of rats induced immediate distur-
bances of colonic motility which were abolished by
the administration of a leukotriene antagonist." In a
similar study the effects of TNB on the proximal
colon were investigated using cyclooxygenase and 5-
lipoxygenase pathway inhibitors, cytokine antago-
nists and PAF antagonists. It was demonstrated that
TNB-induced colitis in rats involves dysmotility in-
volving PAF and IL-1, but not other eicosanoids. Our
data suggest that PAF is stimulated by TNB and may
participate in colonic dysmotility disturbances during
inflammatory states of the left colon. Studies in an
effort to determine whether endogenously stimu-
lated PAF by TNB results in neuropeptide release
similar to that seen with intra-arterial PAF infusion
are currently in progress.
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